Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Sometimes credited toward the program for new patients
Epithalon is currently being researched as a potential drug for Her-2/neu positive breast cancer and in preventing the development of certain types of leukemia and testicular cancer
This protocol outlines its use with a 50 mg vial, reconstituted to a specific concentration for subcutaneous administration, with varying dosage regimens for research purposes
You might also notice more headaches, irritability, or even mouth sores
Use this page as research context, not as a treatment plan
US$ 27.90
US$ 20.69
US$ 21.24
US$ 24.97
US$ 24.44
US$ 20.22
US$ 23.03
US$ 29.44
